Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 20 Αυγ 2021 · For people with suspected obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) or chronic obstructive pulmonary disease–obstructive sleep apnoea/hypopnoea syndrome (COPD–OSAHS) overlap syndrome who are being referred to a sleep service, provide information on:

  2. CPAP is considered the first-line treatment modality for OHS phenotype with concomitant severe obstructive sleep apnoea, whereas NIV is preferred in the minority of OHS patients with hypoventilation during sleep with no or milder forms of obstructive sleep apnoea (approximately <30% of OHS patients).

  3. 3 Νοε 2017 · Obstructive Sleep Apnea has been receiving more and more attention while the diagnostic rate of Obesity Hypoventilation Syndrome is not high. Few studies directly evaluated the relationship between them. We systematically analyzed the relevance of the two diseases.

  4. Continuous positive airway pressure therapy remains the most widely prescribed treatment for obstructive sleep apnea but poor tolerance is a common barrier to effective treatment. Sustainable weight loss is an important treatment option but can be difficult to achieve without bariatric surgery.

  5. 1 Νοε 2020 · Noninvasive ventilation versus CPAP as initial treatment of obesity hypoventilation syndrome: a systematic review

  6. If the sleep evaluation demonstrates OHS and severe obstructive sleep apnea (OSA) (apnea–hypopnea index ≥ 30), the panel recommends continuous positive airway pressure (CPAP) titration and treatment.

  7. Obesity is a well-recognized risk factor in the development of sleep-disordered breathing. Sleep-disordered breathing is defined as an abnormal pattern of breathing during sleep and encompasses condi-tions of varying severity, from snoring to sleep apnea through to obe-sity hypoventilation syndrome.1